Why is Vaishali Pharma falling/rising?

As of 04-Sep, Vaishali Pharma Ltd's stock price is currently at 12.15, reflecting a decrease of 0.01, or 0.08%. The stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 81.53% compared to the 5-day average. The stock has underperformed in the short term, with a 1-week return of -1.54% and a 1-month return of -2.41%. The company's weak long-term fundamentals are highlighted by a staggering -145.73% CAGR growth in operating profits over the last five years and a poor EBIT to Interest ratio of 1.68, which raises concerns about its ability to service debt. Furthermore, the company reported a decline in PAT for the quarter ending June 25, falling by 24.7%, and has generated a return of -35.35% over the past year, indicating a troubling trend in profitability.
In the broader market context, the Sensex has shown a positive return of 0.95% over the past week, contrasting sharply with Vaishali Pharma's negative performance. This divergence suggests that the stock is not only struggling in isolation but is also lagging behind the overall market trends. The company's performance has been below par in both the long term and near term, underperforming the BSE500 index over the last three years, one year, and three months. Given these factors, the stock's recent decline can be attributed to both its weak financial fundamentals and the broader market's relative strength.